Sleep disorders in Parkinson's disease

被引:10
作者
Comella, Cynthia L. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1007/s11940-008-0023-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Sleep disorders in Parkinson's disease (PD) are frequent and have numerous etiologies. Both nighttime sleep disturbances and daytime sleepiness can occur. The key to effective treatment is appropriate diagnosis. A careful interview of the patient and his or her bed partner provides direction for additional evaluations. Referral to a sleep specialist for quantitative studies is necessary to evaluate for rapid eye movement (REM) sleep behavior disorder, sleep apnea, periodic limb movements, and other sleep disorders. Excessive daytime sleepiness may be attributed to interrupted nighttime sleep or daytime medications (particularly the dopamine agonists) or it may be intrinsic to PD. When the diagnosis is established, treatment is directed toward the primary sleep disturbance. Fragmented sleep due to recurrence of PD symptoms may improve with the use of long-acting preparations of carbidopa/levodopa. Sleep apnea is treated using continuous positive airway pressure, and REM sleep behavior disorder may improve using pharmacologic interventions, although controlled trials are lacking. Restless legs syndrome and periodic limb movements during sleep are treated with direct dopaminergic agonists at bedtime. Excessive daytime sleepiness related to the use of direct dopaminergic agonists may improve with dosage reduction or discontinuation. Stimulants such as modafinil may provide modest benefit.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 59 条
[1]  
Abe Kazuo, 2005, No To Shinkei, V57, P301
[2]   Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease [J].
Adler, CH ;
Caviness, JN ;
Hentz, JG ;
Lind, M ;
Tiede, J .
MOVEMENT DISORDERS, 2003, 18 (03) :287-293
[3]   Parkinson's disease and sleepiness - An integral part of PD [J].
Arnulf, I ;
Konofal, E ;
Merino-Andreu, M ;
Houeto, JL ;
Mesnage, V ;
Welter, ML ;
Lacomblez, L ;
Golmard, JL ;
Derenne, JP ;
Agid, Y .
NEUROLOGY, 2002, 58 (07) :1019-1024
[4]   Efficacy of cabergoline in long-term use: Results of three observational studies in 1,500 patients with Parkinson's disease [J].
Baas, HKJ ;
Schueler, P .
EUROPEAN NEUROLOGY, 2001, 46 :18-23
[5]   Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients [J].
Boeve, BF ;
Silber, MH ;
Ferman, TJ .
SLEEP MEDICINE, 2003, 4 (04) :281-284
[6]   Sleepiness in Parkinson's disease: A controlled study [J].
Brodsky, MA ;
Godbold, J ;
Roth, T ;
Olanow, CW .
MOVEMENT DISORDERS, 2003, 18 (06) :668-672
[7]   THE PITTSBURGH SLEEP QUALITY INDEX - A NEW INSTRUMENT FOR PSYCHIATRIC PRACTICE AND RESEARCH [J].
BUYSSE, DJ ;
REYNOLDS, CF ;
MONK, TH ;
BERMAN, SR ;
KUPFER, DJ .
PSYCHIATRY RESEARCH, 1989, 28 (02) :193-213
[8]   The Parkinson's disease sleep scale:: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease [J].
Chaudhuri, KR ;
Pal, S ;
DiMarco, A ;
Whately-Smith, C ;
Bridgman, K ;
Mathew, R ;
Pezzela, FR ;
Forbes, A ;
Högl, B ;
Trenkwalder, C .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (06) :629-635
[9]   Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients [J].
Cicolin, A ;
Lopiano, L ;
Zibetti, M ;
Torre, E ;
Tavella, A ;
Guastamacchia, G ;
Terreni, A ;
Makrydakis, G ;
Fattori, E ;
Lanotte, MM ;
Bergamasco, B ;
Mutani, R .
SLEEP MEDICINE, 2004, 5 (02) :207-210
[10]  
Comella CL, 2006, J NEURAL TRANSM-SUPP, P349